Alector, Inc.

ALEC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$1.51+0.00%

2026-08-03

Financials

Valuation Metrics

Alector, Inc.'s Market Cap is $168M. At end of 2025 it was $161M. Ranked #3042 of 3,111 in US market (top 98%), #1387 of 1,445 on NASDAQ (top 96%), #256 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 95%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$168M	US#3,042/3,111 Sec#256/269
Revenue	$18M	US#2,916/3,111 Sec#177/269
Net Income	$-125M	US—/3,111 Sec—/269
Total Assets	$240M	US#2,961/3,111 Sec#241/269
Net Assets	$58M	US#2,935/3,111 Sec#241/269
Value
P/B	2.90x	US#1,654/3,111 Sec#85/269
P/S	9.10x	US#2,634/3,111 Sec#114/269
FCF Yield	-103.31%	US—/3,111 Sec—/269
Profitability
ROA	-52.26%	US#2,985/3,111 Sec#224/269
Op. Margin	-741.33%	US#2,919/3,111 Sec#175/269
Revenue Growth	-71.53%	US#2,912/3,111 Sec#171/269
Financial Health
Debt Ratio	397.72%	US#2,287/3,111 Sec#229/269
Total Debt	$35M	US#2,645/3,111 Sec#165/269
FCF	$-173M	US#2,716/3,111 Sec#205/269
Cash	$77M	US#2,370/3,111 Sec#198/269
Current Ratio	5.25x	US#448/3,111 Sec#141/269
Performance
1Y Return	4.14%	US#1,986/3,111 Sec#196/269
1M Return	-26.70%	US#2,939/3,111 Sec#251/269
From 52W High	-55.59%	US#2,845/3,111 Sec#230/269
1Y MDD	-65.66%	US#2,845/3,111 Sec#236/269
Trading
Volume	356,387 shares	US#1,944/3,111 Sec#192/269
Trading Value	$534580.00	US#3,024/3,111 Sec#258/269
Per Share
EPS	$-1.39	US—/3,111 Sec—/269
BPS	$0.30	US#2,708/3,111 Sec#229/269